BASILISA PACHECO: Open Payments
NPI 1790023570 · WOODLAND PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 62 payments from 16 companies in 2025. Trend: 2023 $931 · 2024 $1,253 · 2025 $1,135
Food & beverage: $923Education: $213
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 26 | $297 |
| AstraZeneca Pharmaceuticals LP | 8 | $166 |
| SANOFI-AVENTIS U.S. LLC | 1 | $98 |
| United Therapeutics Corporation | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 1 | $81 |
| Verona Pharma, Inc. | 4 | $68 |
| Viatris Specialty LLC | 3 | $59 |
| Philips North America LLC | 3 | $56 |
| Insmed, Inc. | 3 | $50 |
| Amgen Inc. | 1 | $34 |
Products named: NUCALA, DUPIXENT, Tyvaso, TEZSPIRE, Ohtuvayre, YUPELRI, Vest Therapy Und, Arikayce.
Industry payments across NJ — which companies pay providers there.
